1. Cholesterol-rich lysosomes induced by respiratory syncytial virus promote viral replication by blocking autophagy flux.
- Author
-
Chen L, Zhang J, Xu W, Chen J, Tang Y, Xiong S, Li Y, Zhang H, Li M, and Liu Z
- Subjects
- Humans, Animals, Mice, Dynactin Complex metabolism, Endoplasmic Reticulum metabolism, Dyneins metabolism, Adaptor Proteins, Signal Transducing metabolism, Adaptor Proteins, Signal Transducing genetics, Respiratory Syncytial Virus, Human physiology, Autophagosomes metabolism, Viral Fusion Proteins metabolism, Viral Fusion Proteins genetics, HeLa Cells, A549 Cells, Autophagy, Lysosomes metabolism, Cholesterol metabolism, Virus Replication, rab7 GTP-Binding Proteins, Receptors, LDL metabolism, Receptors, LDL genetics, Respiratory Syncytial Virus Infections metabolism, Respiratory Syncytial Virus Infections virology, Vesicular Transport Proteins metabolism, Vesicular Transport Proteins genetics, rab GTP-Binding Proteins metabolism, rab GTP-Binding Proteins genetics
- Abstract
Respiratory syncytial virus (RSV) hijacks cholesterol or autophagy pathways to facilitate optimal replication. However, our understanding of the associated molecular mechanisms remains limited. Here, we show that RSV infection blocks cholesterol transport from lysosomes to the endoplasmic reticulum by downregulating the activity of lysosomal acid lipase, activates the SREBP2-LDLR axis, and promotes uptake and accumulation of exogenous cholesterol in lysosomes. High cholesterol levels impair the VAP-A-binding activity of ORP1L and promote the recruitment of dynein-dynactin, PLEKHM1, or HOPS VPS39 to Rab7-RILP, thereby facilitating minus-end transport of autophagosomes and autolysosome formation. Acidification inhibition and dysfunction of cholesterol-rich lysosomes impair autophagy flux by inhibiting autolysosome degradation, which promotes the accumulation of RSV fusion protein. RSV-F storage is nearly abolished after cholesterol depletion or knockdown of LDLR. Most importantly, the knockout of LDLR effectively inhibits RSV infection in vivo. These findings elucidate the molecular mechanism of how RSV co-regulates lysosomal cholesterol reprogramming and autophagy and reveal LDLR as a novel target for anti-RSV drug development., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF